Achieving the therapeutic benefits of Niaspan® in daily practice

Charles A. Reasner

doi:10.1093/eurheartj/sul044

Achieving the therapeutic benefits of Niaspan® in daily practice

Charles A. Reasner

Medicine

Research output: Contribution to journal › Review article

5 Scopus citations

Abstract

Aims: The purpose of this aricle is to discuss the use of niacin to reduce cardiovascular events in patients with diabetes. Methods and Results: Five common misconceptions regarding the use of niacin are discussed and practical suggestions to decrease flushing with niacin are outlined. Evidence that combining niacin with statin therapy is presented. Conclusions: That simultaneous lowering of LDL-cholesterol with statins and raising HDL-cholesterol with niacin is a rational and effective strategy for preventing cardiovascular disease in patients with diabetes.

Original language	English (US)
Pages (from-to)	F68-F73
Journal	European Heart Journal, Supplement
Volume	8
Issue number	F
DOIs	https://doi.org/10.1093/eurheartj/sul044
State	Published - Oct 1 2006

Keywords

Dyslipidaemia
HDL-cholesterol
Niacin
Nicotinic acid
Type 2 diabetes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1093/eurheartj/sul044

Fingerprint Dive into the research topics of 'Achieving the therapeutic benefits of Niaspan® in daily practice'. Together they form a unique fingerprint.

Cite this

Reasner, C. A. (2006). Achieving the therapeutic benefits of Niaspan® in daily practice. European Heart Journal, Supplement, 8(F), F68-F73. https://doi.org/10.1093/eurheartj/sul044

@article{34848fce077b442b986cd1771c50ef53,

title = "Achieving the therapeutic benefits of Niaspan{\textregistered} in daily practice",

abstract = "Aims: The purpose of this aricle is to discuss the use of niacin to reduce cardiovascular events in patients with diabetes. Methods and Results: Five common misconceptions regarding the use of niacin are discussed and practical suggestions to decrease flushing with niacin are outlined. Evidence that combining niacin with statin therapy is presented. Conclusions: That simultaneous lowering of LDL-cholesterol with statins and raising HDL-cholesterol with niacin is a rational and effective strategy for preventing cardiovascular disease in patients with diabetes.",

keywords = "Dyslipidaemia, HDL-cholesterol, Niacin, Nicotinic acid, Type 2 diabetes",

author = "Reasner, {Charles A.}",

year = "2006",

month = oct,

day = "1",

doi = "10.1093/eurheartj/sul044",

language = "English (US)",

volume = "8",

pages = "F68--F73",

journal = "European Heart Journal, Supplement",

issn = "1520-765X",

publisher = "Oxford University Press",

number = "F",

}

TY - JOUR

T1 - Achieving the therapeutic benefits of Niaspan® in daily practice

AU - Reasner, Charles A.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Aims: The purpose of this aricle is to discuss the use of niacin to reduce cardiovascular events in patients with diabetes. Methods and Results: Five common misconceptions regarding the use of niacin are discussed and practical suggestions to decrease flushing with niacin are outlined. Evidence that combining niacin with statin therapy is presented. Conclusions: That simultaneous lowering of LDL-cholesterol with statins and raising HDL-cholesterol with niacin is a rational and effective strategy for preventing cardiovascular disease in patients with diabetes.

AB - Aims: The purpose of this aricle is to discuss the use of niacin to reduce cardiovascular events in patients with diabetes. Methods and Results: Five common misconceptions regarding the use of niacin are discussed and practical suggestions to decrease flushing with niacin are outlined. Evidence that combining niacin with statin therapy is presented. Conclusions: That simultaneous lowering of LDL-cholesterol with statins and raising HDL-cholesterol with niacin is a rational and effective strategy for preventing cardiovascular disease in patients with diabetes.

KW - Dyslipidaemia

KW - HDL-cholesterol

KW - Niacin

KW - Nicotinic acid

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=33749005931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749005931&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/sul044

DO - 10.1093/eurheartj/sul044

M3 - Review article

AN - SCOPUS:33749005931

VL - 8

SP - F68-F73

JO - European Heart Journal, Supplement

JF - European Heart Journal, Supplement

SN - 1520-765X

IS - F

ER -